User profiles for Laurie A. Lee
Laurie A LeeDuke, GSK Verified email at gsk.com Cited by 4028 |
Egg oral immunotherapy in nonanaphylactic children with egg allergy
…, PH Steele, L Pons, RM Helm, LA Lee… - Journal of allergy and …, 2007 - Elsevier
BACKGROUND: There is no current active treatment for food allergy. Traditional injection
immunotherapy has been proved unsafe, and thus there is a need for other forms of …
immunotherapy has been proved unsafe, and thus there is a need for other forms of …
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind …
LA Lee, Z Bailes, N Barnes, LP Boulet… - The Lancet …, 2021 - thelancet.com
Background Despite inhaled corticosteroid plus long-acting β 2 -agonist (ICS/LABA) therapy,
30–50% of patients with moderate or severe asthma remain inadequately controlled. We …
30–50% of patients with moderate or severe asthma remain inadequately controlled. We …
Food allergies: prevalence, molecular characterization, and treatment/prevention strategies
▪ Abstract A significant proportion of the population is either affected by or concerned about
food allergy. Our knowledge about food allergens and how they stimulate the immune system …
food allergy. Our knowledge about food allergens and how they stimulate the immune system …
[HTML][HTML] Safety of adding salmeterol to fluticasone propionate in children with asthma
Background Long-acting beta-agonists (LABAs) have been shown to increase the risk of
asthma-related death among adults and the risk of asthma-related hospitalization among …
asthma-related death among adults and the risk of asthma-related hospitalization among …
[HTML][HTML] A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline
…, J Kromm, AE LeBlanc, K Lee-Ameduri, LA Lee… - Canadian Journal of …, 2023 - Springer
This 2023 Clinical Practice Guideline provides the biomedical definition of death based on
permanent cessation of brain function that applies to all persons, as well as …
permanent cessation of brain function that applies to all persons, as well as …
[HTML][HTML] The effect of fluticasone furoate/umeclidinium in adult patients with asthma: a randomized, dose-ranging study
Background We evaluated the dose–response of umeclidinium (UMEC; a long-acting
muscarinic antagonist) combined with fluticasone furoate (FF; an inhaled corticosteroid [ICS]) in …
muscarinic antagonist) combined with fluticasone furoate (FF; an inhaled corticosteroid [ICS]) in …
[HTML][HTML] Physiological and functional alterations after spaceflight and bed rest
… Lee SMC, Feiveson AH, Stein S, Stenger MB, Platts SH. Orthostatic intolerance after ISS
and space shuttle missions. Aerosp Med Hum Perform. … Gillen CM, Lee R, Mack GW …
and space shuttle missions. Aerosp Med Hum Perform. … Gillen CM, Lee R, Mack GW …
Clinical characteristics of peanut-allergic children: recent changes
OBJECTIVE. The goal was to determine whether patients seen in a referral clinic are experiencing
initial allergic reactions to peanuts earlier, compared with a similar population profiled …
initial allergic reactions to peanuts earlier, compared with a similar population profiled …
Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis
LA Lee, R Sterling, J Máspero, D Clements… - The Journal of Allergy …, 2014 - Elsevier
… Lee is employed by and has stock/stock options in GlaxoSmithKline. R. Sterling was a
principal investigator for Carolina Research Inc, which participated in the clinical trial. …
principal investigator for Carolina Research Inc, which participated in the clinical trial. …
[HTML][HTML] A randomized, three-period crossover study of umeclidinium as monotherapy in adult patients with asthma
Background To our knowledge, no studies in patients with asthma have assessed a long-acting
muscarinic antagonist in the absence of inhaled corticosteroids (ICS). Objective …
muscarinic antagonist in the absence of inhaled corticosteroids (ICS). Objective …